The Enterprise Value as of September 2024 (TTM) for Gritstone bio, Inc. (GRTS) is 115.09M

According to Gritstone bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 115.09M. This represents a change of -52.74% compared to the average of 243.50M of the last 4 quarters.

Gritstone bio, Inc. (GRTS) Historical Enterprise Value (quarterly & annually)

How has GRTS Enterprise Value performed in the past?

The mean historical Enterprise Value of Gritstone bio, Inc. over the last ten years is 302.46M. The current 115.09M Enterprise Value has changed 3.71% with respect to the historical average. Over the past ten years (40 quarters), GRTS's Enterprise Value was at its highest in in the December 2021 quarter at 933.32M. The Enterprise Value was at its lowest in in the September 2018 quarter at -22541392.85.

Gritstone bio, Inc. (GRTS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gritstone bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gritstone bio, Inc. (GRTS) Average Enterprise Value

How has GRTS Enterprise Value performed in the past?

The current Enterprise Value of Gritstone bio, Inc. (GRTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Gritstone bio, Inc. (GRTS) Enterprise Value vs. Peers

How is GRTS’s Enterprise Value compared to its peers?

Gritstone bio, Inc.’s Enterprise Value is less than Aurinia Pharmaceuticals Inc. (1.06B), less than BridgeBio Pharma, Inc. (6.06B), greater than Annovis Bio, Inc. (105.13M), less than ImmunoGen, Inc. (8.19B), less than Generation Bio Co. (238.32M), greater than Kronos Bio, Inc. (12.40M), less than Erasca, Inc. (697.60M), less than C4 Therapeutics, Inc. (437.68M), less than Edgewise Therapeutics, Inc. (1.75B), greater than Kezar Life Sciences, Inc. (31.39M), less than Fulcrum Therapeutics, Inc. (137.61M), greater than Passage Bio, Inc. (44.68M), greater than InflaRx N.V. (58.81M), less than Allogene Therapeutics, Inc. (525.79M), less than G1 Therapeutics, Inc. (410.05M), less than Heron Therapeutics, Inc. (456.08M), less than Annexon, Inc. (605.08M), less than Sangamo Therapeutics, Inc. (175.61M), greater than Affimed N.V. (58.94M), greater than Leap Therapeutics, Inc. (32.20M), greater than Adaptimmune Therapeutics plc (101.47M), less than Corvus Pharmaceuticals, Inc. (328.64M), greater than Aptose Biosciences Inc. (-122263.00),

Build a custom stock screener for Gritstone bio, Inc. (GRTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gritstone bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gritstone bio, Inc. (GRTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gritstone bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.